258 related articles for article (PubMed ID: 29753232)
1. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
Ding N; Kwak L; Ballew SH; Jaar B; Hoogeveen RC; Ballantyne CM; Sharrett AR; Folsom AR; Heiss G; Salameh M; Coresh J; Hirsch AT; Selvin E; Matsushita K
Atherosclerosis; 2018 Jul; 274():86-93. PubMed ID: 29753232
[TBL] [Abstract][Full Text] [Related]
2. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.
Parrinello CM; Selvin E
Curr Diab Rep; 2014; 14(11):548. PubMed ID: 25249070
[TBL] [Abstract][Full Text] [Related]
3. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
Rooney MR; Tang O; Pankow JS; Selvin E
Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
[TBL] [Abstract][Full Text] [Related]
4. High hemoglobin A
Arya S; Binney ZO; Khakharia A; Long CA; Brewster LP; Wilson PW; Jordan WD; Duwayri Y
J Vasc Surg; 2018 Jan; 67(1):217-228.e1. PubMed ID: 28844470
[TBL] [Abstract][Full Text] [Related]
5. Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.
Parrinello CM; Sharrett AR; Maruthur NM; Bergenstal RM; Grams ME; Coresh J; Selvin E
Diabetes Care; 2016 Apr; 39(4):589-95. PubMed ID: 26681712
[TBL] [Abstract][Full Text] [Related]
6. Visit-to-visit variability of glycated albumin was associated with incidence or progression of lower extremity atherosclerotic disease.
Shen Y; Dai D; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
Cardiovasc Diabetol; 2020 Dec; 19(1):211. PubMed ID: 33302958
[TBL] [Abstract][Full Text] [Related]
7. Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study.
Ding N; Yang C; Ballew SH; Kalbaugh CA; McEvoy JW; Salameh M; Aguilar D; Hoogeveen RC; Nambi V; Selvin E; Folsom AR; Heiss G; Coresh J; Ballantyne CM; Matsushita K
Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2322-2331. PubMed ID: 32698688
[TBL] [Abstract][Full Text] [Related]
8. Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study.
Selvin E; Rawlings AM; Grams M; Klein R; Sharrett AR; Steffes M; Coresh J
Lancet Diabetes Endocrinol; 2014 Apr; 2(4):279-288. PubMed ID: 24703046
[TBL] [Abstract][Full Text] [Related]
9. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
Jung M; Warren B; Grams M; Kwong YD; Shafi T; Coresh J; Rebholz CM; Selvin E
J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090
[TBL] [Abstract][Full Text] [Related]
10. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
11. Nontraditional markers of glycemia: associations with microvascular conditions.
Selvin E; Francis LM; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL; Steffes MW
Diabetes Care; 2011 Apr; 34(4):960-7. PubMed ID: 21335368
[TBL] [Abstract][Full Text] [Related]
12. Alternative markers of hyperglycemia and risk of diabetes.
Juraschek SP; Steffes MW; Miller ER; Selvin E
Diabetes Care; 2012 Nov; 35(11):2265-70. PubMed ID: 22875225
[TBL] [Abstract][Full Text] [Related]
13. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Juraschek SP; Steffes MW; Selvin E
Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
[TBL] [Abstract][Full Text] [Related]
14. Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort.
Cha JJ; Kim H; Ko YG; Choi D; Lee JH; Yoon CH; Chae IH; Yu CW; Lee SW; Lee SR; Choi SH; Koh YS; Min PK;
Cardiovasc Diabetol; 2020 Jun; 19(1):97. PubMed ID: 32571352
[TBL] [Abstract][Full Text] [Related]
15. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
Beck R; Steffes M; Xing D; Ruedy K; Mauras N; Wilson DM; Kollman C;
Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
[TBL] [Abstract][Full Text] [Related]
16. Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes.
Yang CP; Lin CC; Li CI; Liu CS; Lin CH; Hwang KL; Yang SY; Li TC
Cardiovasc Diabetol; 2020 Jan; 19(1):4. PubMed ID: 31910828
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.
Selvin E; Warren B; He X; Sacks DB; Saenger AK
Clin Chem; 2018 May; 64(5):843-850. PubMed ID: 29436378
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin A
Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
[TBL] [Abstract][Full Text] [Related]
19. Fructosamine and Glycated Albumin and the Risk of Cardiovascular Outcomes and Death.
Selvin E; Rawlings AM; Lutsey PL; Maruthur N; Pankow JS; Steffes M; Coresh J
Circulation; 2015 Jul; 132(4):269-77. PubMed ID: 26022911
[TBL] [Abstract][Full Text] [Related]
20. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
Chan CL; Pyle L; Kelsey M; Newnes L; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
